WESTFORD, Mass., Nov. 9, 2015 /PRNewswire/
-- Cynosure, Inc. (NASDAQ: CYNO), which develops and
markets laser- and light-based aesthetic treatment systems for
high-volume applications, today announced that Chairman and Chief
Executive Officer Michael Davin and
Tim Baker, the Company's President
and Chief Financial Officer, will be participating in two upcoming
investor conferences:
- Brean Capital 2015 Life Science Summit on Monday, November 16 at the Millennium Broadway
Hotel in New York City.
- Stifel Healthcare Conference on Tuesday, November 17 at 10:15 a.m. (ET) at The New York Palace Hotel in
New York City. This will be a
fireside chat format.
A live audio webcast of the Stifel presentation will be
available on the "Investor Relations" section of the Company's
website at www.cynosure.com. An archived presentation will be
available for 90 days.
About Cynosure, Inc.
Cynosure develops, manufactures, and markets aesthetic treatment
systems that enable plastic surgeons, dermatologists and other
medical practitioners to perform non-invasive and minimally
invasive procedures to remove hair, treat vascular and benign
pigmented lesions, remove multi-colored tattoos, revitalize the
skin, reduce fat through non-invasive and minimally invasive laser
lipolysis, reduce cellulite, clear nails infected by toe fungus,
ablate sweat glands and improve vaginal health. Cynosure also
markets radiofrequency energy-sourced medical devices for precision
surgical applications such as facial plastic and general surgery,
gynecology, ear, nose, and throat procedures, ophthalmology, oral
and maxillofacial surgery, podiatry and proctology. Cynosure's
product portfolio is composed of a broad range of energy sources
including Alexandrite, diode, Nd:YAG, picosecond, pulse dye,
Q-switched lasers, intense pulsed light and radiofrequency
technology. Cynosure sells its products globally under the
Cynosure, Palomar, ConBio and Ellman brand names through a direct
sales force in the United States,
Canada, Mexico, France, Morocco, Germany, Spain, the United
Kingdom, Australia,
China, Japan and Korea, and through international
distributors in approximately 120 other countries. For
corporate or product information, visit Cynosure's website at
www.cynosure.com.
Contact:
Scott
Solomon
Senior Vice President
Sharon Merrill Associates,
Inc.
617.542.5300
cyno@investorrelations.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cynosure-to-participate-in-upcoming-investor-conferences-300174696.html
SOURCE Cynosure, Inc.